Gemcitabine Hydrochloride This page contains brief information about gemcitabine hydrochloride and a collection of links to more information about the use of this drug, related research results, and ongoing clinical trials. US Brand Name(s): | ![](https://webarchive.library.unt.edu/eot2008/20090829223720im_/http://www.cancer.gov/images/spacer.gif) | Gemzar | ![](https://webarchive.library.unt.edu/eot2008/20090829223720im_/http://www.cancer.gov/images/spacer.gif) | ![](https://webarchive.library.unt.edu/eot2008/20090829223720im_/http://www.cancer.gov/images/spacer.gif) | FDA Approved: | ![](https://webarchive.library.unt.edu/eot2008/20090829223720im_/http://www.cancer.gov/images/spacer.gif) | Yes |
Gemcitabine hydrochloride is approved by the Food and Drug Administration (FDA) to be used by itself to treat pancreatic cancer that is advanced or has metastasized (spread to other parts of the body). It is used in patients who cannot be treated with surgery and have already been treated with other chemotherapy. Gemcitabine hydrochloride is approved to be used with other drugs to treat the following: - Ovarian cancer that is advanced and has not gotten better with other chemotherapy.
- Breast cancer that has metastasized (spread to other parts of the body) and has not gotten better with other chemotherapy.
- Non-small cell lung cancer (NSCLC) that is advanced, cannot be treated with surgery, or has metastasized (spread to other parts the body).
Gemcitabine hydrochloride is also being studied in the treatment of other types of cancer.
Information from the FDA
FDA Approval for Gemcitabine Hydrochloride - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.
Information from the NCIDefinition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trial Results: Treatment Regimen Extends Survival for Women with Cervical Cancer - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Combination Treatment Boosts Survival in Biliary Tract Cancers - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Gemcitabine Plus Carboplatin Benefits Women with Recurrent Ovarian Cancer - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Gemcitabine Plus Standard Chemoradiation Improves Survival in Patients with Pancreatic Head Tumors - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Gemcitabine after Pancreatic Cancer Surgery Improves Survival - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Erlotinib Plus Gemcitabine Boosts One-Year Survival in Pancreatic Cancer - Important clinical trial results for this drug, background information, and how the trial was done.
Information from the National Library of Medicine (NLM)
MedlinePlus Information on Gemcitabine Hydrochloride - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. Clinical TrialsClinical Trials for Gemcitabine Hydrochloride - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.
Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
Back to Top |